- Home
- KROS vs CARE Comparison
KROS vs CARE Comparison
Compare KROS & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CARE
- Stock Information
- Founded
- KROS 2015
- CARE 1974
- Country
- KROS United States
- CARE United States
- Employees
- KROS N/A
- CARE N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CARE Major Banks
- Sector
- KROS Health Care
- CARE Finance
- Exchange
- KROS Nasdaq
- CARE Nasdaq
- Market Cap
- KROS 565.0M
- CARE 456.8M
- IPO Year
- KROS 2020
- CARE N/A
- Fundamental
- Price
- KROS $15.91
- CARE $19.00
- Analyst Decision
- KROS Buy
- CARE
- Analyst Count
- KROS 14
- CARE 0
- Target Price
- KROS $20.56
- CARE N/A
- AVG Volume (30 Days)
- KROS 424.2K
- CARE 85.5K
- Earning Date
- KROS 11-05-2025
- CARE 10-24-2025
- Dividend Yield
- KROS N/A
- CARE N/A
- EPS Growth
- KROS N/A
- CARE 154.06
- EPS
- KROS 0.47
- CARE 1.36
- Revenue
- KROS $232,844,000.00
- CARE $153,120,000.00
- Revenue This Year
- KROS $6,657.47
- CARE $10.85
- Revenue Next Year
- KROS N/A
- CARE $14.12
- P/E Ratio
- KROS $34.14
- CARE $13.76
- Revenue Growth
- KROS 85820.30
- CARE 21.78
- 52 Week Low
- KROS $9.12
- CARE $13.61
- 52 Week High
- KROS $72.37
- CARE $20.53
- Technical
- Relative Strength Index (RSI)
- KROS 54.08
- CARE 44.31
- Support Level
- KROS $15.50
- CARE $18.95
- Resistance Level
- KROS $16.44
- CARE $19.61
- Average True Range (ATR)
- KROS 0.57
- CARE 0.43
- MACD
- KROS -0.01
- CARE -0.11
- Stochastic Oscillator
- KROS 59.87
- CARE 19.12
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.